Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

US FDA allows sale of abortion pills at pharmacies for first time

Regulatory change to expand abortion access comes after more than a dozen states banned abortion.

Al Jazeera

The FDA finalizes rule expanding the availability of abortion pills

The Food and Drug Administration on Tuesday finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.

WEKU

‘Critically important’ rule change allowing mail-order abortion pills finalised by FDA

The move replaces a long-standing requirement that they pick up the medicine in person – although its impact has been blunted by numerous state laws limiting abortion broadly and the pills specifically

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Retail pharmacies can offer abortion pills, FDA says

Certified pharmacies can now dispense abortion pills.

Axios

A TikTok trend sold out Ozempic, leaving people with diabetes dizzy, scared

For more than a month, Shane Anthony, a 57-year-old auto mechanic, hasn’t been able to get his diabetes medication.

Tribune News Service

Where does Missouri get the drugs it uses to execute prisoners? The supplier is a secret

KANSAS CITY, Mo. — For the first time since 2015, Missouri has returned to executing multiple people on death row per year — two in 2022 and two scheduled so far for 2023 — but details about the process remain shrouded in secrecy.

Tribune News Service

Experts: Underuse of COVID-19 drug Paxlovid shortchanging patients

ATLANTA -- Ira Katz bustles at his pharmacy in Atlanta's Little Five Points neighborhood this cough season, serving patients who need medicine for respiratory viruses like COVID-19. He dispenses occasional packages of Paxlovid, a drug designed to nip COVID in the bud. But there aren’t as many of those Paxlovid…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

FDA’s approval of Biogen Alzheimer’s drug slammed in report

U.S. health officials’ approval process for Biogen Inc.’s controversial Alzheimer’s drug was “rife with irregularities,” raising serious concerns about protocol lapses at the agency, congressional investigators said.

Tribune News Service

News briefs

House report questions FDA’s approval of Alzheimer’s drug

Tribune News Service

Probe: Alzheimer's drug approval 'rife with irregularities'

The Food and Drug Administration's contentious approval of a questionable Alzheimer's drug is taking another hit

The Independent UK

House report questions FDA’s approval of Alzheimer’s drug

WASHINGTON — A joint investigation released Thursday by House Democrats identified unusual collaboration between Food and Drug Administration officials and drugmaker Biogen, highlighting potential problems in the agency’s approval of the controversial Alzheimer’s drug Aduhelm.

Tribune News Service

Evie’s smart ring is ‘designed for women’ and aimed at challenging Oura

The Evie smart ring targets women's health and is aiming to be FDA-approved. Movano says it will ideally cost less than $300 when it launches sometime in 2023.

Inverse

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

StockNews.com

House report questions FDA's approval of Alzheimer's drug - Roll Call

House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.

Roll Call

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

A simple device could prevent thousands of maternal deaths. Why did it take so long to get to market?

Alydia Health's Jada system for postpartum hemorrhage took 11 years to reach the market; being a women's health product made its road tougher.

StockNews.com

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

The Independent UK

Making pig livers humanlike in quest to ease organ shortage

Scientists are transforming pig livers to look and act like human ones, part of a quest to ease the nation's organ shortage

WEKU

FDA changes Plan B label to clarify 'morning-after' pill doesn't cause abortion

The agency in a memo Friday said the emergency contraception pills are not the same as abortion pills — which end a pregnancy — a fact that has long been understood in the medical community.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA changes Plan B label, clarifies it won't cause abortion

The Food and Drug Administration announced Friday that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

New label law has unintended effect: Sesame in more foods

A new federal law requiring that sesame be listed as an allergen on food labels is having unintended consequences _ increasing the number of products that include the ingredient

Axios

Congress saves big health care decisions for last

The health care riders in the year-end spending package that emerged on Monday reflect which health care interests have clout, and which issues lawmakers want to punt into next year.

Tribune News Service

States challenge Biden to lower drug prices by allowing imports from Canada

The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.

The Independent UK

Panel warns FDA’s beleaguered tobacco unit lacks direction

A new report criticizes the Food and Drug Administration’s efforts to oversee the tobacco industry, including traditional cigarettes and vaping products

Tribune News Service

Medtronic sees 23 serious medical device recalls in two years

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

1 … 159 160 161 162

People

Mangeet Kaur BounsMangeet

Alexis McGill Johnson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.